Fixed-dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications.
作者信息
DiPette Donald J, Skeete Jamario, Ridley Emily, Campbell Norm R C, Lopez-Jaramillo Patricio, Kishore Sandeep P, Jaffe Marc G, Coca Antonio, Townsend Raymond R, Ordunez Pedro
机构信息
University of South Carolina School of Medicine, University of South Carolina, Columbia, South Carolina.
Palmetto Health, Columbia, South Carolina.
出版信息
J Clin Hypertens (Greenwich). 2019 Jan;21(1):4-15. doi: 10.1111/jch.13426. Epub 2018 Nov 27.
Abstract
摘要
相似文献
1
Fixed-dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications.固定剂量复方药物治疗以改善全球高血压控制：临床视角与政策影响
J Clin Hypertens (Greenwich). 2019 Jan;21(1):4-15. doi: 10.1111/jch.13426. Epub 2018 Nov 27.
2
Cardiovascular risk stratification in Chinese patients with hypertension.中国高血压患者的心血管风险分层
J Clin Hypertens (Greenwich). 2019 Oct;21(10):1607-1608. doi: 10.1111/jch.13680. Epub 2019 Sep 9.
3
Adding a low-dose antihypertensive regimen would substantially improve the control of hypertension and reduce cardiovascular morbidity among uncomplicated hypertensive patients.在未合并其他疾病的高血压患者中，添加一种低剂量降压方案可显著改善高血压的控制，并降低心血管发病率。
Eur J Prev Cardiol. 2012 Aug;19(4):712-22. doi: 10.1177/1741826711410835. Epub 2011 May 24.
4
Some thoughts about recent hypertension trials.关于近期高血压试验的一些思考。
Clin Cardiol. 2007 Jun;30(6):268-70. doi: 10.1002/clc.20152.
5
Combination therapy for the management of hypertension: A review of the evidence.联合治疗高血压的管理：证据回顾。
Am J Health Syst Pharm. 2010 Jun 1;67(11):885-94. doi: 10.2146/ajhp090419.
6
[Principles of antihypertensive therapy in metabolic syndrome].[代谢综合征的降压治疗原则]
Klin Med (Mosk). 2013;91(6):4-8.
7
[Fixed-dose combinations in the first line of antihypertensive therapy].[抗高血压治疗一线固定剂量复方制剂]
Acta Pharm Hung. 2007;77(3):180-4.
8
Fixed-dose combination therapy in the treatment of hypertension: ready for prime time.固定剂量复方疗法治疗高血压：已准备好进入黄金时代。
South Med J. 2007 Apr;100(4):343-4. doi: 10.1097/SMJ.0b013e3180374ef1.
9
Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension.以收缩压为目标：控制收缩压/舒张压联合高血压的关键。
Am J Hypertens. 2006 Sep;19(9):985-6. doi: 10.1016/j.amjhyper.2006.03.012.
10
Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.固定剂量复方制剂治疗高血压的理论依据：循环往复。
Drugs. 2002;62(3):443-62. doi: 10.2165/00003495-200262030-00003.
引用本文的文献
1
Retrospective Electronic Medical Records Study to Understand the Usage Patterns and Patient Profiles of Those Prescribed Amlodipine and Its Combinations.回顾性电子病历研究以了解使用氨氯地平及其复方制剂患者的用药模式和患者概况。
Cureus. 2025 Jul 29;17(7):e88954. doi: 10.7759/cureus.88954. eCollection 2025 Jul.
2
Association Between Fixed-Dose Combination Use and Medication Adherence, Health Care Utilization, and Costs Among Medicaid Beneficiaries.医疗补助受益人群中固定剂量复方药物使用与药物依从性、医疗保健利用及费用之间的关联
JACC Adv. 2025 Aug 21;4(9):102091. doi: 10.1016/j.jacadv.2025.102091.
3
Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1.在基层医疗卫生机构整合高血压与心血管-肾脏-代谢护理的候选干预措施：HEARTS 2.0 第一阶段
Glob Heart. 2025 May 27;20(1):45. doi: 10.5334/gh.1428. eCollection 2025.
4
Optimizing Blood Pressure Control: A Randomized Comparative Trial of Losartan/Chlorthalidone vs. Losartan/Hydrochlorothiazide.优化血压控制：氯沙坦/氯噻酮与氯沙坦/氢氯噻嗪的随机对照试验
Cardiol Ther. 2025 Jun;14(2):231-247. doi: 10.1007/s40119-025-00407-7. Epub 2025 Apr 24.
5
HEARTS Pharmacy: A framework for integrating pharmacists in hypertension and cardiovascular disease risk management in primary care.心脏药房：将药剂师纳入初级保健中高血压和心血管疾病风险管理的框架。
Rev Panam Salud Publica. 2025 Apr 18;49:e35. doi: 10.26633/RPSP.2025.35. eCollection 2025.
6
Acceptability of fixed-dose combination treatments for hypertension in Kenya: A qualitative study using the Theoretical Framework of Acceptability.肯尼亚高血压固定剂量复方治疗的可接受性：一项基于可接受性理论框架的定性研究
PLOS Glob Public Health. 2025 Mar 18;5(3):e0003012. doi: 10.1371/journal.pgph.0003012. eCollection 2025.
7
Three spectrophotometric quantitative analysis of bisoprolol fumarate and telmisartan in fixed-dose combination utilizing ratio spectra manipulation methods.利用比率光谱操作法对富马酸比索洛尔和替米沙坦固定剂量复方制剂进行三种分光光度法定量分析。
Sci Rep. 2024 Oct 2;14(1):22899. doi: 10.1038/s41598-024-72525-6.
8
Comparing scale up of status quo hypertension care against dual combination therapy as separate pills or single pill combinations: an economic evaluation in 24 low- and middle-income countries.比较现状高血压护理与作为分开药丸或单片复方制剂的双重联合疗法的扩大规模情况：24个低收入和中等收入国家的经济评估。
EClinicalMedicine. 2024 Aug 27;75:102778. doi: 10.1016/j.eclinm.2024.102778. eCollection 2024 Sep.
9
A Cross-Sectional Survey of Fixed-Dose Combination Antihypertensive Medicine Prescribing in Twenty-Four Countries, Including Qualitative Insights.一项对24个国家固定剂量复方抗高血压药物处方的横断面调查，包括定性见解。
Glob Heart. 2024 Sep 12;19(1):73. doi: 10.5334/gh.1353. eCollection 2024.
10
Global consumption patterns of combination hypertension medication: An analysis of pharmaceutical sales data from 2010-2021.复方高血压药物的全球消费模式：对2010年至2021年药品销售数据的分析
PLOS Glob Public Health. 2024 Sep 6;4(9):e0003698. doi: 10.1371/journal.pgph.0003698. eCollection 2024.
本文引用的文献
1
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
2
Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.加拿大高血压学会 2018 年成人和儿童高血压诊断、风险评估、预防和治疗指南。
Can J Cardiol. 2018 May;34(5):506-525. doi: 10.1016/j.cjca.2018.02.022. Epub 2018 Mar 1.
3
Recommended treatment protocols to improve management of hypertension globally: A statement by Resolve to Save Lives and the World Hypertension League (WHL).改善全球高血压管理的推荐治疗方案：“决心拯救生命”组织与世界高血压联盟（WHL）的声明
J Clin Hypertens (Greenwich). 2018 May;20(5):829-836. doi: 10.1111/jch.13280. Epub 2018 Apr 27.
4
Fixed-dose combinations: A valuable tool to improve adherence to antihypertensive treatment.固定剂量复方制剂：提高抗高血压治疗依从性的一项重要工具。
J Clin Hypertens (Greenwich). 2018 May;20(5):908-909. doi: 10.1111/jch.13299. Epub 2018 Apr 27.
5
The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis.固定剂量复方制剂与自由等效复方制剂治疗高血压对依从性的影响：一项荟萃分析。
J Clin Hypertens (Greenwich). 2018 May;20(5):902-907. doi: 10.1111/jch.13272. Epub 2018 Apr 27.
6
Standardized Hypertension Management to Reduce Cardiovascular Disease Morbidity and Mortality Worldwide.全球标准化高血压管理以降低心血管疾病发病率和死亡率
South Med J. 2018 Mar;111(3):133-136. doi: 10.14423/SMJ.0000000000000776.
7
Fixed-dose vs free-dose combinations for the management of hypertension-An analysis of 81 958 patients.固定剂量与自由剂量联合治疗高血压-对 81958 例患者的分析。
J Clin Hypertens (Greenwich). 2018 Apr;20(4):705-715. doi: 10.1111/jch.13240. Epub 2018 Feb 19.
8
Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data.在高收入、中等收入和低收入国家，降压药物的可及性和可负担性及其对血压控制的影响：对 PURE 研究数据的分析。
Lancet Public Health. 2017 Sep;2(9):e411-e419. doi: 10.1016/S2468-2667(17)30141-X. Epub 2017 Sep 5.
9
Best antihypertensive strategies to improve blood pressure control in Latin America: position of the Latin American Society of Hypertension.改善拉丁美洲血压控制的最佳降压策略：拉丁美洲高血压学会立场。
J Hypertens. 2018 Feb;36(2):208-220. doi: 10.1097/HJH.0000000000001593.
10
Saving an additional 100 million lives.再拯救1亿人的生命。
Lancet. 2018 Feb 17;391(10121):709-712. doi: 10.1016/S0140-6736(17)32443-1. Epub 2017 Sep 12.
Zotero 插件